Live Breaking News & Updates on Kingray Capital

Stay updated with breaking news from Kingray capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Chinese biopharma firm IMPACT closes $55m Series D+ round to advance cancer drugs

The Series D+ round was led by GTJA Investment Group and Beijing-based state capital investor Kingray Capital. ....

Leiwen Chen , Junshi Biosciences , National Medical Products Administration , Yangzhou Guojin Group , Investment Group , Drug Administration , Yangzhou City , Lilly Asia Ventures , New Drug Application , Kingray Capital , Eikon Therapeutics , Hong Kong Listed , Wuxi Apptec , Cenova Ventures , Decheng Capital ,

Chinese biopharmaceutical firm Atom Bioscience snaps over $82m in Series D round

Biopharmaceutical firm Jiangsu Atom Bioscience and Pharmaceutical has bagged 600 million yuan ($82.8 million) in a Series D funding round. ....

Fund Management , Unifortune Investment Holdings Group , Atom Bioscience , Kaitai Capital , Fortune Capital , Kingray Capital ,

DAS Solar bags funding and 48 more updates from Greater China worth about $853m

Previously, the Quzhou-headquartered firm secured an undisclosed sum in February, joined by China Renaissance, and CICC Capital, among others. ....

Sinopec Group , Capital Operation Group , Power Investment Corporation , Industrial Fund Management , Beijing Financial Street Capital Operation , Kingray Capital , Fund Management , State Power Investment Corporation , Sinopec Capital , Huatai Zijin Investment , China Renaissance , Jolmo Capital , Huge Capital , Puhua Capital ,

Chinese advanced polymer materials maker TopOlefin snags $139m in Series B round

TopOlefin Technology has raked in 1 billion yuan ($138.9 million) in a Series B round led by local PE investment firms Kingray Capital and Raystone Capital. ....

Ofound Angel , Jiangsu Libert , Topolefin Technology , Quzhou Based Topolefin Technology , Kingray Capital , Graystone Capital , Shangrong Capital Management , Highlight Capital , Biotrack Capital , Cobetter Filtration ,

Chinese biotech firm Trinomab closes $104m pre-IPO round to advance product pipeline

The round was led by PE investment firm Kingray Capital and Gree Financial Investment. ....

Hong Kong , Chen Leiwen , Zhuhai Gree Group , Jinhang Group , Wuxi Guolian Development , Asia Hillhouse Capital Group , Trinomab Biotech , Kingray Capital , Gree Financial Investment , Zhuhai Gree , Efung Capital , Wanguo Investment , Wanguo Securities , Hong Kong Listed , China Medical System , Zhuhai City , Riverhead Capital , Hillhouse Capital ,